Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > After reading thru the details on Mesoblast's NR

<< Previous

Bullboard Posts

Next >>

Comment by PingPong888on May 03, 2020 3:14pm

147 Views

Post# 30981388

RE:RE:After reading thru the details on Mesoblast's NR

1) The US government had put a hold on stem cell research summer of 2019 due to poligical reasons to support religious group buy-ins

2) COVID came into effect winter 2019

3) Lock down in 2020 occured winter/spring of 2020

4) Worldwide desperation for tests, treatments and cures

5) Stem cells are being allowed back into research mode ONLY for those that do not harm babies (i.e. abortion). This applies to LBL - as it does not harm babies.

6) LBL is probably going through rigourous procedures with FDA and IROCC before annoucing results.

False claims can bankrupt this company.

If the results are good, this stock will move up trastically since it is one of the very very VERY few doing stem cells.

I hope I answers part of your questions.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment